17 Mar 2023 Next 51 Labs to Focus on Reducing Maternal Mortality in the U.S. With Capital From Laerdal Million Lives Fund Press Releases CHICAGO…
17 Mar 2023 DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation Press Releases
17 Mar 2023 Agendia Announces First Patient Enrolled in PROOFS Registry Trial to Determine Optimal Treatment and Ability to Forgo Chemotherapy for Premenopausal Women with Early HR+ Breast Cancer Press Releases …
17 Mar 2023 Matrivax Initiates Phase 1 Clinical Development of MVX01, a Novel Pneumococcal Vaccine Candidate Press Releases BOSTON–(
17 Mar 2023 Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease Press Releases LITTLE…
17 Mar 2023 FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer’s PAXLOVID™ Press Releases
17 Mar 2023 Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Press Releases
17 Mar 2023 Alpine Immune Sciences to Present Povetacicept (ALPN-303) Phase 1 (RUBY-1) Study Data at the 2023 American Academy of Dermatology Annual Meeting Press Releases SEATTLE&…
